Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 10, Number 9, 1 September 2012

Favourites:
ADD

Free Content Activated protein C: reasons to believe
pp. 1733-1735(3)
Authors: MONTES, R.; DÍEZ, J.; HERMIDA, J.

Favourites:
ADD

Free Content Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart
pp. 1736-1744(9)
Authors: COSTA, R.; MORRISON, A.; WANG, J.; MANITHODY, C.; LI, J.; REZAIE, A. R.

Favourites:
ADD

Free Content Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
pp. 1745-1751(7)
Authors: MIKKELSEN, A. P.; LINDHARDSEN, J.; LIP, G. Y. H.; GISLASON, G. H.; TORP‐PEDERSEN, C.; OLESEN, J. B.

Favourites:
ADD

Free Content Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism
pp. 1752-1760(9)
Authors: NAUFFAL, D.; BALLESTER, M.; REYES, R. LOPEZ; JIMÉNEZ, D.; OTERO, R.; QUINTAVALLA, R.; MONREAL, M.; The RIETE Investigatorscr8

Favourites:
ADD

Free Content The relationship between body mass index, activated protein C resistance and risk of venous thrombosis
pp. 1761-1767(7)
Authors: CHRISTIANSEN, S. C.; LIJFERING, W. M.; NÆSS, I. A.; HAMMERSTRØM, J.; van HYLCKAMA VLIEG, A.; ROSENDAAL, F. R.; CANNEGIETER, S. C.

Favourites:
ADD

Free Content Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study
pp. 1768-1774(7)
Authors: HO, K. M.; YIP, C. B.; DUFF, O.

Favourites:
ADD

Free Content Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism
pp. 1783-1791(9)
Authors: BUCCIARELLI, P.; PASSAMONTI, S. M.; BIGUZZI, E.; GIANNIELLO, F.; FRANCHI, F.; MANNUCCI, P. M.; MARTINELLI, I.

Favourites:
ADD

Free Content A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom
pp. 1792-1801(10)
Authors: CAMILLERI, R. S.; SCULLY, M.; THOMAS, M.; MACKIE, I. J.; LIESNER, R.; CHEN, W. J.; MANNS, K.; MACHIN, S. J.

Favourites:
ADD

Free Content Intra‐articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII‐deficient mice
pp. 1802-1813(12)
Authors: KASHIWAKURA, Y.; OHMORI, T.; MIMURO, J.; YASUMOTO, A.; ISHIWATA, A.; SAKATA, A.; MADOIWA, S.; INOUE, M.; HASEGAWA, M.; OZAWA, K.; SAKATA, Y.

Favourites:
ADD

Free Content The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII
pp. 1814-1822(9)
Authors: LAPALUD, P.; ALI, T.; CAYZAC, C.; MATHIEU‐DUPAS, E.; LEVESQUE, H.; PFEIFFER, C.; BALICCHI, J.; GRUEL, Y.; BORG, J. Y.; SCHVED, J. F.; GRANIER, C.; LAVIGNE‐LISSALDE, G.

Favourites:
ADD

Free Content Increased anticoagulant response to low‐molecular‐weight heparin in plasma from patients with advanced cirrhosis
pp. 1823-1829(7)
Authors: SENZOLO, M.; RODRIGUEZ‐Castro, K. I.; ROSSETTO, V.; RADU, C.; GAVASSO, S.; CARRARO, P.; ZERBINATI, P.; SARTORI, M. T.; SIMIONI, P.

Favourites:
ADD

Free Content Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate
pp. 1830-1840(11)
Authors: LAMBOURNE, M. D.; ELTRINGHAM‐SMITH, L. J.; GATAIANCE, S.; ARNOLD, D. M.; CROWTHER, M. A.; SHEFFIELD, W. P.

Favourites:
ADD

Free Content Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
pp. 1841-1848(8)
Authors: PRAGST, I.; ZEITLER, S. H.; DOERR, B.; KASPEREIT, F. J.; HERZOG, E.; DICKNEITE, G.; van RYN, J.

Favourites:
ADD

Free Content The tick‐derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells
pp. 1849-1858(10)
Authors: CARNEIRO‐LOBO, T. C.; SCHAFFNER, F.; DISSE, J.; OSTERGAARD, H.; FRANCISCHETTI, I. M. B.; MONTEIRO, R. Q.; RUF, W.

Favourites:
ADD

Free Content Type II antithrombin deficiency caused by a large in‐frame insertion: structural, functional and pathological relevance
pp. 1859-1866(8)
Authors: MARTÍNEZ‐MARTÍNEZ, I.; JOHNSON, D. J. D.; YAMASAKI, M.; NAVARRO‐FERNÁNDEZ, J.; ORDÓÑEZ, A.; VICENTE, V.; HUNTINGTON, J. A.; CORRAL, J.

Favourites:
ADD

Free Content Identification of Hic‐5 as a novel regulatory factor for integrin αIIbβ3 activation and platelet aggregation in mice
pp. 1867-1874(8)
Authors: KIM‐KANEYAMA, J.‐R.; MIYAUCHI, A.; LEI, X.‐F.; ARITA, S.; MINO, T.; TAKEDA, N.; KOU, K.; ETO, K.; YOSHIDA, T.; MIYAZAKI, T.; SHIODA, S.; MIYAZAKI, A.

Favourites:
ADD
Favourites:
ADD

Free Content Protein kinase Cε and protein kinase C double‐deficient mice have a bleeding diathesis
pp. 1887-1894(8)
Authors: UNSWORTH, A. J.; FINNEY, B. A.; NAVARRO‐NUNEZ, L.; SEVERIN, S.; WATSON, S. P.; PEARS, C. J.

Favourites:
ADD

Free Content Tissue factor‐Akt signaling triggers microvessel formation
pp. 1895-1905(11)
Authors: ARDERIU, G.; PEÑA, E.; ALEDO, R.; BADIMON, L.

Favourites:
ADD

Free Content Mobilization of CD34+KDR+ endothelial progenitor cells predicts target lesion revascularization
pp. 1906-1913(8)
Authors: BONELLO, L.; HARHOURI, K.; BAUMSTARCK, K.; ARNAUD, L.; LESAVRE, N.; PIOT, C.; PAGANELLI, F; DIGNAT‐GEORGE, F.; SABATIER, F.

Favourites:
ADD

Free Content Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential
pp. 1914-1928(15)
Authors: BENNIS, Y.; SARLON‐BARTOLI, G.; GUILLET, B.; LUCAS, L.; PELLEGRINI, L.; VELLY, L.; BLOT‐CHABAUD, M.; DIGNAT‐GEORGES, F.; SABATIER, F.; PISANO, P.

Favourites:
ADD

Free Content Shear stress is required for the endocytic uptake of the factor VIII‐von Willebrand factor complex by macrophages
pp. 1929-1937(9)
Authors: CASTRO‐NÚÑEZ, L.; DIENAVA‐VERDOOLD, I.; HERCZENIK, E.; MERTENS, K.; MEIJER, A. B.

Favourites:
ADD

Free Content Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity
pp. 1938-1943(6)
Authors: PEYVANDI, F.; DI MICHELE, D.; BOLTON‐MAGGS, P. H. B.; LEE, C. A.; TRIPODI, A.; SRIVASTAVA, A.; for the Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasiscr7

Favourites:
ADD
Favourites:
ADD

Free Content Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity
pp. 1946-1949(4)
Authors: LHERMUSIER, T.; VOISIN, S.; MEJEAN, S.; GARCIA, C.; SIÉ, P.; CARRIÉ, D.

Favourites:
ADD

Free Content On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes
pp. 1949-1951(3)
Authors: MATSUURA, E.; GUYER, K.; YAMAMOTO, H.; LOPEZ, L. R.; INOUE, K.

Favourites:
ADD

Free Content Utility of multiplex ligation‐dependent probe amplification (MLPA) for hemophilia mutation screening
pp. 1951-1954(4)
Authors: PAYNE, A. B.; BEAN, C. J.; HOOPER, W. C.; MILLER, C. H.

Favourites:
ADD

Free Content Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A
pp. 1954-1960(7)
Authors: COPPOLA, A.; TAGLIAFERRI, A.; FRANCHINI, M.

Favourites:
ADD

Free Content Observations regarding the immunogenicity of BDD‐rFVIII derived from a mechanistic personalized medicine perspective
pp. 1961-1965(5)
Authors: SAUNA, Z. E.; AMERI, A.; KIM, B.; YANOVER, C.; VIEL, K. R.; RAJALINGAM, R.; COLE, S. A.; HOWARD, T. E.

Favourites:
ADD

Free Content P2X7 regulation of macrophage tissue factor activity and microparticle generation
pp. 1965-1967(3)
Authors: LEE, R.; WILLIAMS, J. C.; MACKMAN, N.

Favourites:
ADD

Free Content Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia
pp. 1967-1970(4)
Authors: COLELLA, M. P.; De PAULA, E. V.; CONRAN, N.; MACHADO‐NETO, J. A.; ANNICCHINO‐BIZZACCHI, J. M.; COSTA, F. F.; SAAD, S. T. O.; TRAINA, F.

Favourites:
ADD

Free Content More on: optimal dose for stroke thrombolysis in Asians
pp. 1970-1971(2)
Authors: AHMAD, A.; SHARMA, V. K.

Favourites:
ADD

Free Content Heparin concentrations in neonates during cardiopulmonary bypass: a rebuttal
pp. 1972-1972(1)
Authors: IGNJATOVIC, V.; NEWALL, F.; MONAGLE, P.

Favourites:
ADD

Free Content Thrombolysis for normotensive patients with acute symptomatic pulmonary embolism: a rebuttal
pp. 1973-1974(2)
Authors: KLINE, J. A.; POLLACK, C. V.; SCHREIBER, D.; BRIESE, B.

Favourites:
ADD

Free Content Thrombolysis for normotensive patients with acute symptomatic pulmonary embolism: reply to a rebuttal
pp. 1974-1975(2)
Authors: JIMÉNEZ, D.; RIERA‐MESTRE, A.; MONREAL, M.; YUSEN, R. D.

Favourites:
ADD

Free Content Join ISTH
pp. 1976-1977(2)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more